Ironwood Pharmaceuticals Inc (IRWD) insider trading

Every open-market stock purchase and sale by Ironwood Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $22M over the last 12 months (10 sales). No open-market buys.
  • Last insider buy: Jon R Duane (Insider), $60.2K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $22M (10 sales). Last close $3.31 on Jun 4, 2026.

Recent IRWD insider trades

DateInsiderTradeValue
Jun 16, 2026Julie McHugh (Insider)Sold$80.5K
Jun 16, 2026Julie McHugh (Insider)Bought (not open market)—
Jun 16, 2026Catherine Moukheibir (Insider)Bought (not open market)—
Jun 16, 2026Jay Shepard (Insider)Bought (not open market)—
Jun 16, 2026Alexander J Denner (Insider)Bought (not open market)—
Jun 16, 2026Marla L Kessler (Insider)Bought (not open market)—
Jun 16, 2026Jon R Duane (Insider)Bought (not open market)—
Jun 16, 2026Mark G Currie (Insider)Bought (not open market)—
Jun 15, 2026Alexander J Denner (Insider)Bought (not open market)—
May 19, 2026Ronald Silver (Insider)Bought (not open market)—
Mar 17, 2026Alexander J Denner (Insider)Sold$20.5M
Mar 17, 2026Alexander J Denner (Insider)Sold$19.2K
Mar 13, 2026Alexander J Denner (Insider)Bought (not open market)—
Mar 10, 2026Thomas A MCCOURT (CEO)Bought (not open market)—
Mar 10, 2026Tammi L Gaskins (C-suite exec)Bought (not open market)—
Mar 10, 2026Minardo John (C-suite exec)Bought (not open market)—
Mar 10, 2026Gregory S. Martini (CFO)Bought (not open market)—
Mar 10, 2026Michael Shetzline (C-suite exec)Bought (not open market)—
Mar 10, 2026Ronald Silver (Insider)Bought (not open market)—
Feb 24, 2026Thomas A MCCOURT (CEO)Sold$379K
Feb 24, 2026Minardo John (C-suite exec)Sold$69.7K
Feb 24, 2026Michael Shetzline (C-suite exec)Sold$62.3K
Feb 24, 2026Ronald Silver (Insider)Sold$46.2K
Feb 24, 2026Gregory S. Martini (CFO)Sold$41.9K
Feb 24, 2026Tammi L Gaskins (C-suite exec)Sold$41.1K

Who's trading IRWD

Get free alerts when an insider at Ironwood Pharmaceuticals Inc files a new trade →